ArticleAntimicrobial agents and chemotherapy2020

Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.

Lindsay Broadbent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.